| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |